TED Ted Baker Plc

RNS Number:8070A
Tepnel Life Sciences PLC
21 March 2001

For immediate release
    21 March, 2001


Tepnel Life Sciences Announces Appointment of New Chief Executive Officer

Tepnel Life Sciences plc is pleased to announce the appointment of Benjamin
Matzilevich as Chief Executive Officer.  Mr. Matzilevich has specialised in
the development of technology growth companies and brings twenty two years of
executive management experience in the Biotechnology industry to the position.

Mr. Matzilevich has held senior positions and worked as a consultant with a
variety of pharmaceutical and biotechnology companies, including Eli Lilly &
Co., Unilever, Lederle Laboratories, NEN Corporation, and CN Bioscience Inc.

Peter Raymond, Chairman of Tepnel Life Sciences, commented:

"We are delighted that Mr. Matzilevich has decided to join Tepnel.  Ben brings
with him a wealth of expertise and knowledge of building profitable companies
in the biotech industry and will play a key role in Tepnel's continued
development."

Benjamin Matzilevich, Chief Executive Officer, commented:

"I am pleased to join Tepnel and believe that the company is well positioned
to take advantage of exciting new developments in the biotech industry.  I
look forward to working with management to assure Tepnel's growth and success
in the future."

Enquiries:

Tepnel Life Sciences                    0161-445-9457
Ben Matzilevich, Chief Executive
Mike Billingham, Commercial Director
Carol Smith, Communications Manager

Hudson Sandler                          020-7796-4133
Piers Hooper
Jessica Rouleau

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024